Anti-Grapevine Leafroll-Associated Virus 3 (GLRaV-3) IgG Fraction Monoclonal Antibody (clone 5A5/C2)

Anti-Grapevine Leafroll-Associated Virus 3 (GLRaV-3) IgG Fraction Monoclonal Antibody (clone 5A5/C2)

Catalog Number:
A001277678AUS
Mfr. No.:
AUST_AM-1502ZA-5
Price:
$760
  • Size:
    100µg
    Quantity:
    Add to Cart:
      • Overview
        • Mouse monoclonal antibody IgG fraction (clone 5A5/C2) obtained by immunizing mice with a recombinant coat protein of GLRaV-3. The IgG fraction was purified using Protein G-Sepharose.

          Please contact us at for specific academic pricing.

      • Properties
        • Antibody Type
          monoclonal
          Isotype
          IgG1
          Formulation
          Solution at 1 mg/mL in PBS. Some of the liquid in the vial could have evaporated with changes in the final volume. However, the mass of the protein is still inside the vial.
          Storage
          Store at -20°C.

          * For research use ONLY in laboratory animals and in vitro testing. NOT for diagnostic or human use.

      • Applications
        • Application Description
          This monoclonal antibody reacts with extracts of GLRaV-3-infected plants in ELISA, DAS-ELISA, immunocapture-RT-PCR and Western blot (1: 1,000 dilution). GLRaV-3 belongs to the genus Ampelovirus of the family Closteroviridae and its genome is composed by a single-stranded positive-sense RNA with a 35-39 kDa coat protein. GLRaV-3 virions have a flexuous filamentous morphology, it is phloem-limited and transmitted by several species of mealybugs. The leafroll disease is one of the most destructive viral deseases of grapevines wordlwide.
      • Reference
        • Lanza, M. et. al. (2010) Trop. Plant Pathol. 35, 377-380.
          Engel, E. et. al. (2008) Virus Genes 37, 110-118.
          Tsai, C.W. et .al. (2008) Phytopathology 98, 1093-1098.
          Turturo, C. et. al. (2005) J. Gen. Virol. 86, 217-224.

    Note: If you don't receive our verification email, do the following:

    Copyright © Amerigo Scientific. All rights reserved.